Search
Search Results
-
POEMS syndrome with undetectable M-protein: a case report and literature review
BackgroundPolyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare plasma cell (PC) neoplasm with...
-
Low serum total cholesterol levels predict inferior prognosis of patients with POEMS syndrome
Low serum cholesterol levels are associated with increased tumor morbidity and mortality. However, the relationship between serum lipid profile and...
-
Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome
BackgroundTo investigate the utility of regular serum VEGF (sVEGF) levels assessment in the monitoring of POEMS syndrome.
MethodsWe retrospectively...
-
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion
The standard therapies for polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes (POEMS) syndrome are radiation therapy,...
-
-
Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome
ObjectiveTo evaluate the clinical characteristics and outcomes of patients with nephropathy associated with POEMS syndrome who received novel agents...
-
Raynaud’s phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report
BackgroundPOEMS syndrome is a rare paraneoplastic syndrome caused by plasma cell disorder almost always lambda restricted. Secondary Raynaud’s...
-
Clinical features of POEMS syndrome in Southeast Asia: a literature-based study
To determine and analyze the clinical characteristics of POEMS syndrome among Southeast Asian countries. We searched the literature using a...
-
-
Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome
POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome is a rare plasma cell dyscrasia without...
-
-
Cerebral large artery stenosis and occlusion in POEMS syndrome
BackgroundThis study aimed to investigate the frequency and risk factors for cerebral artery stenosis and occlusion in patients with polyneuropathy,...
-
-
Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases
BackgroundPolyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare multisystemic clonal...
-
Peripheral retinal leakage in POEMS syndrome
BackgroundPOEMS (polyneuropathy, organomegaly, endocrinopathy, myeloma protein, skin changes) syndrome is a rare blood disorder with multi-system...
-
A highly heterogeneous mutational pattern in POEMS syndrome
POEMS syndrome is a rare plasma cell dyscrasia. Little is known about its pathogenesis and genetic features. We analyzed the mutational features of...
-
Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone
POEMS syndrome is a rare plasma cell disorder. Lenalidomide has recently emerged as a therapeutic option for POEMS syndrome. Cereblon has been...
-
-
-